Disposables in Russia Rise in Prices while Drop in Sales

Market by 2FIRSTS.ai
Apr.23.2024
Disposables in Russia Rise in Prices while Drop in Sales
Russian e-cigarette market sees 18% price increase in 2024, while traditional cigarette prices rise by 10%, sales drop.

According to Russian news outlet RT, the price of disposable e-cigarettes in the Russian market has increased by 18% in 2024, reaching approximately 1300 rubles. At the same time, sales have decreased by 31% compared to last year. Research by experts shows that the average price of regular cigarettes in 2024 is 202 rubles. Data indicates that the average price of cigarettes has risen by 10%, while sales have decreased by 2%.

 

Furthermore, the research also notes that the average price of e-cigarette heaters is around 1000 rubles, with sales decreasing by 1%. On the other hand, the average price of heating rods in tobacco heating systems is 222 rubles, with a price increase of 9%, but sales only increasing by 1%.

 

According to Russian Duma member Sultan Khamzaev, a series of anti-smoking laws were passed last year and have had a positive impact. He emphasized that cigarette advertising and displaying cigarettes in shop windows are completely prohibited. However, there are still some business owners who are not complying with these laws.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris USA Reaches $66M Settlement With Washington State Over MSA Payment Dispute
Philip Morris USA Reaches $66M Settlement With Washington State Over MSA Payment Dispute
Philip Morris USA has reached a settlement with Washington State and agreed to pay $66 million to resolve disputes over annual payments under the 1998 Master Settlement Agreement (MSA) for the period 2005–2015.
Nov.04 by 2FIRSTS.ai
ZYN Rolls Out “X-Low” Campaign in the UK to Target Low-Strength Nicotine Pouch Market
ZYN Rolls Out “X-Low” Campaign in the UK to Target Low-Strength Nicotine Pouch Market
Philip Morris International’s (PMI) nicotine pouch brand ZYN has launched an “X-Low” low-strength campaign in the UK, accelerating its push into the ultra-low nicotine pouch segment, with updated packaging and new flavours already rolled out in both the UK and the Philippines.
Dec.09 by 2FIRSTS.ai
Product | LOST MARY launches X-LINK series on its Russian website: near-identical to ELFBAR JOINOne, plus two new adjustable pods
Product | LOST MARY launches X-LINK series on its Russian website: near-identical to ELFBAR JOINOne, plus two new adjustable pods
LOST MARY has officially launched the X-LINK e-cigarette series on its Russian website. The lineup closely mirrors ELFBAR’s JOINOne in architecture and features, and adds two new adjustable pods—one for sweetness control and one for nicotine strength—expanding the compatible pod types to four (cooling/ice, classic, sweetness-adjustable, and nicotine-adjustable).
Dec.01 by 2FIRSTS.ai
Australia’s TGA Seizes Illicit Vaping Products Worth Over  US$670,000 in Bendigo
Australia’s TGA Seizes Illicit Vaping Products Worth Over US$670,000 in Bendigo
Australia’s Therapeutic Goods Administration (TGA) has seized illicit vaping products with an estimated street value exceeding A$1 million (approximately US$670,000) following an enforcement operation in Bendigo, Victoria.
Dec.24 by 2FIRSTS.ai
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Heaven Gifts’s HNB Brand REJO Launches New Device with Design Strikingly Similar to ELFBAR JOINOne Series
Miracle’s heated tobacco brand REJO has launched its new device REJO CUBE in Dubai. The device’s industrial design is highly similar to the ELFBAR JOINOne series, featuring a left-right magnetic structure and side-mounted screen. Positioning the Middle East as a key market, REJO is moving ahead with local team building and entity setup in the region.
Nov.14 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai